Roche at PEGS Europe 2026
Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website
Roche brings 9 presentations to PEGS Europe 2026 in Lisbon. Its program centres on the design and safety of bispecific and multispecific antibodies, from protease-activated T cell engagers to how complex antibody formats behave in the body. Other work covers a bispecific that mimics a clotting factor for hemophilia A.
| Organization | PEGS Europe 2026 Attendance |
|---|---|
Roche Basel, Switzerland | |
Swiss pharmaceutical and diagnostics company whose research units discover and develop antibodies, bispecifics and other biologic medicines. | Chair Tue Nov 17 8:25am–8:30am Talk Tue Nov 17 11:45am–12:15pm Talk Tue Nov 17 2:05pm–2:35pm Talk Wed Nov 18 9:30am–10:00am Talk Wed Nov 18 2:35pm–3:05pm Talk Wed Nov 18 2:35pm–3:05pm Talk Wed Nov 18 6:25pm–6:50pm Talk Thu Nov 19 11:15am–11:45am Talk Thu Nov 19 11:45am–12:15pm |
Instantly find 20 buyers from Roche
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction